Source:http://linkedlifedata.com/resource/pubmed/id/19375663
Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
5
|
pubmed:dateCreated |
2009-4-20
|
pubmed:abstractText |
Despite the inconsistent or weak association between cholesterol and stroke, lowering of cholesterol concentrations with statins reduces the risk of stroke in high-risk populations and in patients with non-cardioembolic stroke or transient ischaemic attack. Statin therapy is the most important advance in stroke prevention since the introduction of aspirin and antihypertensive treatments. Meta-analysis of randomised trials of statins in combination with other preventive strategies, including 165 792 individuals, shows that each 1 mmol/L (39 mg/dL) decrease in LDL cholesterol equates to a reduction in relative risk for stroke of 21.1% (95% CI 6.3-33.5, p=0.009). In secondary prevention of non-cardioembolic stroke, intense reduction of LDL cholesterol by statins also significantly reduced the risk of recurrent stroke (relative risk 0.84, 0.71-0.99, p=0.03) and major cardiovascular events (0.80, 0.69-0.92, p=0.002). Future directions include assessment of a target LDL cholesterol concentration of less than 1.8 mmol/L (70 mg/dL), the effects of triglyceride-lowering therapy alone or in combination with statins, and the effects of treatments to raise HDL cholesterol concentrations.
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical | |
pubmed:status |
MEDLINE
|
pubmed:month |
May
|
pubmed:issn |
1474-4422
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:volume |
8
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
453-63
|
pubmed:meshHeading |
pubmed-meshheading:19375663-Aged,
pubmed-meshheading:19375663-Cholesterol, LDL,
pubmed-meshheading:19375663-Female,
pubmed-meshheading:19375663-Humans,
pubmed-meshheading:19375663-Hydroxymethylglutaryl-CoA Reductase Inhibitors,
pubmed-meshheading:19375663-Intracranial Hemorrhages,
pubmed-meshheading:19375663-Male,
pubmed-meshheading:19375663-Middle Aged,
pubmed-meshheading:19375663-Randomized Controlled Trials as Topic,
pubmed-meshheading:19375663-Recurrence,
pubmed-meshheading:19375663-Regression Analysis,
pubmed-meshheading:19375663-Risk Factors,
pubmed-meshheading:19375663-Secondary Prevention,
pubmed-meshheading:19375663-Stroke
|
pubmed:year |
2009
|
pubmed:articleTitle |
Lipid management in the prevention of stroke: review and updated meta-analysis of statins for stroke prevention.
|
pubmed:affiliation |
INSERM U-698 clinical research in atherothrombosis and Paris-Diderot University, Paris, France. pierre.amarenco@bch.aphp.fr
|
pubmed:publicationType |
Journal Article,
Review,
Meta-Analysis
|